Looking toward the future, moving forward together in both directions to promote faster and better development of the pharmaceutical and healthcare industry | Shi Dai, General Manager of China Merchants Group, visits Renfu Pharmaceutical Group for research.

Release time:

2025-07-31 13:44

Source:

On June 12, Shi Dai, General Manager of China Merchants Group. Conducting a research visit in Yichang Renfu Pharmaceutical Group Listen to the briefing. On-site inspection Core Subsidiary Yichang Renfu And give important instructions on the work. China Merchants Group Chief Accountant Wu Bo, China Merchants Group Relevant department officials, Investment Promotion and Technological Innovation, China Merchants Bank, China Longhao Shipping, China Merchants Transportation Science and Technology, Leaders from relevant companies, including China Merchants Shekou, participated in the research visit.

Du Wentao, President of Renfu Pharmaceutical Group, introduced the company’s historical development and strategic direction. Operating performance, Situation regarding industrial and international development strategies, as well as future development plans. And stated that Renfu Pharmaceutical will integrate as soon as possible into the overall strategy of China Merchants Group, actively contributing to the Group’s third entrepreneurial journey and playing a pioneering role. 。

Shi Dai Point out Since its establishment, Renfu Pharmaceutical Group has experienced both hardships and abundant rewards, and has now grown into a modern pharmaceutical enterprise with deep-rooted foundations, broad prospects, and strong competitiveness. Shi Dai stated that China Merchants Group attaches great importance to and holds high expectations for Renfu Pharmaceutical. Looking ahead, the two entities will work together to chart an even more ambitious course of development. We look forward to Renfu Pharmaceutical and China Merchants Group embarking on a mutually beneficial journey, jointly stepping into an even brighter future. Shi Dai emphasized that China Merchants Group’s strategic focus in the future lies in the science and technology innovation industry, particularly in the pharmaceutical and healthcare sectors. Both a traditional industry and an innovative industry of the future. ， is what Zhaoshang Chuangke is focusing on. One of the three major directions: “Life Sciences, Digital Intelligence Technologies, and Green Technologies.” Relying on the China Merchants Group’s strong competitiveness in industries such as transportation and logistics, integrated finance, and real estate parks, Renfu Pharmaceutical is bound to achieve even better and faster development. Shi Dai definitely approves of the proposal put forward by Zhaoshang Chuangke. “MAGIC” business strategy, Sincere expectations Renfu Pharmaceutical Able to continuously cultivate and refine, becoming a group. A crucial and dynamic key platform , with the group internally Deep collaboration among related industries, Close collaboration, Accelerate the commercialization of research findings. Expand into a broader market. , build The “Magic” Legend 。

Shi Dai emphasized that, Future Work at Renfu Pharmaceutical Focus on four-character phrases: First, “Steady.” China Merchants Group Take office It is to promote. Renfu Pharmaceutical To achieve better development, all levels of the enterprise must stabilize morale, solidify the team, and manage expectations. All employees should focus wholeheartedly on production and operations, maintaining a positive momentum of steady progress amid stability. Second, ... “Integration.” For over a century, China Merchants Group has upheld an innovative spirit of daring to lead and bravely standing at the forefront of trends, providing a fundamental guarantee for enterprises’ steady and sustainable development. In its own development journey, Renfu Pharmaceutical has also established a robust operational and management framework. Its meticulous management approach and conscientious work ethic align closely with China Merchants Group’s culture of pragmatism, innovation, and compliance. We look forward to the synergy between the two organizations yielding even better products, building a more outstanding team, and further enhancing organizational capabilities. Third is “Innovation.” Innovation is the very foundation upon which enterprises thrive—and it is also the source of vitality for team innovation. We must fully embed the gene of innovation into our corporate philosophy, management mechanisms, and all institutional frameworks. In particular, we must spare no effort in technological innovation, increase investment, and achieve more breakthroughs. Fourth is “Expansion.” We must aim high, embrace new frontiers, and reach out beyond our borders. While remaining firmly rooted in the domestic market, we must also venture onto the global stage. China Merchants Group’s overseas... of the A broad-based layout will provide enterprises with abundant resources for expanding into international markets.

Shi Dai encourages Renfu Pharmaceutical Continuously innovate and strive for new heights, contributing even more to the nation’s pharmaceutical industry and the health and well-being of the people.

Yin Qiang, Vice President of Renfu Pharmaceutical Group and Chairman of Xinjiang Weiyao; Liu NanHong, Secretary of the Board of Directors; Li Jie, Chairman of Yichang Renfu, and others attended the event.

Miao Jianmin Visits Renfu Pharmaceutical

The Top 100 Pharmaceutical Companies List Has Been Released—Renfu Pharmaceutical Ranks 19th.